Research and Markets: Osteosarcoma Pipeline Highlights - 2014-2017
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/nljdvc/osteosarcoma) has announced the addition of the "Osteosarcoma Pipeline Highlights - 2014 Update" report to their offering.
The latest report Osteosarcoma Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Osteosarcoma market. It covers emerging therapies for Osteosarcoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
- The report provides Osteosarcoma pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
- The report provides Osteosarcoma pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
- The report provides Osteosarcoma pipeline molecules by the Originator Company.
Short-term Launch Highlights:
- Find out which Osteosarcoma pipeline products will be launched in the US and Ex-US till 2017.
- Osteosarcoma phase 3 clinical trial pipeline molecules
- Osteosarcoma phase 2 clinical trial pipeline molecules
- Osteosarcoma phase 1 clinical trial pipeline molecules
- Osteosarcoma preclinical research pipeline molecules
- Osteosarcoma discovery stage pipeline molecules
- Osteosarcoma pipeline molecules short-term launch highlights
For more information visit http://www.researchandmarkets.com/research/nljdvc/osteosarcoma